Rare Disease ?Pipeline Analysis ?Landscape in 2023

Rare Disease ​Pipeline Analysis ​Landscape in 2023


Summary

This report investigates the Rare Disease ​Pipeline Analysis ​Landscape in 2023 in the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot to prioritize these trends within your sector.

Scope

This 29-page report gives important, expert insight you won’t find in any other source. 12 figures throughout the report illustrate major points and trends in Rare Disease. This report is required reading for -
  • Investors that want to understand current rare disease trends impacting the biopharmaceutical industry as well as identifying companies to invest in
  • Companies that are interested in seeing the extent and impact of rare diseases trends and how best to pivot towards it.
  • Large pharma companies with investment groups or BD teams looking to see which rare disease led biopharmaceutical companies lead the industry currently and what their focuses are on
Reasons to Buy

Insights on Drug Development Landscape​
Insights on Leading key companies and sponsors ​
Insights on Upcoming drug launches​
Insights on Innovation Landscape​
Insights on Patent grant trends​
Insights on Leading companies by patents​
Insights on Dealmaking trends ​
Insights on Orphan drug designation approvals over time​


Rare Disease Overview
Regulatory Reforms
Drug Development Landscape
Drugs by therapy area
Drugs by indication
Therapy area sales growth
Leading key companies and sponsors
Upcoming drug launches
Innovation Landscape
Patent grant trends
Leading companies by patents
Dealmaking trends
Orphan drug designation approvals over time
AI Industry Trends
Most Active Companies in AI Development
Therapy Areas by Deal Value and Volume
Key Findings
Appendix
Abbreviations
Methodology
Related Reports
About the Authors
About GlobalData
Contact Us
List of Figures
Therapy Area by Pipeline Drugs 2023
Indications by Pipeline Drugs
Therapy Area Forecast Annual Sales Growth (2023 to 2029)
Drugs by Highest Development Stage
Leading Companies by Drugs in Late-Stage Development
Top Clinical Trial Sponsors in 2024
Top 10 Drug Launches by Sales
Rare Disease Patents Granted Over Time (2018 to 2022)
Leading Patent Assignees (2016 to 2022)
Rare Disease Deals Over Time (2013 to 2022)
Deals by Therapy Area (2018 to 2022)
Orphan Drug Designation Approvals Over Time (2013 to 2022)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings